Once-weekly oral medication with alendronate does not prevent migration of knee prostheses: A double-blind randomized RSA study
2009 (English)In: Acta Orthopaedica, ISSN 1745-3674, E-ISSN 1745-3682, Vol. 80, no 1, 41-45 p.Article in journal (Refereed) Published
Background and purpose
Early migration of joint replacements is an effect of poor fixation and can predict late loosening. By reducing the bone resorption after implantation of a joint replacement, it should be possible to enhance the initial fixation of the implant. We studied the effect of once-weekly treatment with alendronate after knee replacement.
Patients and methods
We recruited 60 patients (60 knees) with gonarthrosis who were scheduled for a total knee replacement. They were operated on with identical implants and uncemented fixation. 30 patients were treated with a bisphosphonate (alendronate) and 30 patients underwent placebo treatment. The treatment started postoperatively and continued on a weekly basis for 6 months. The fixation of the implants was measured with repeated radiostereometry for 2 years.
There was no difference in migration of implants between the two groups.
With uncemented fixation of knee implants, no benefit of once-weekly treatment with alendronate, starting postoperatively, could be seen during a 2-year follow-up period.
Place, publisher, year, edition, pages
Informa Healthcare, 2009. Vol. 80, no 1, 41-45 p.
Medical and Health Sciences
IdentifiersURN: urn:nbn:se:liu:diva-17633DOI: 10.1080/17453670902804968PubMedID: 19297788OAI: oai:DiVA.org:liu-17633DiVA: diva2:210964